Innovative Stem Cell Transplant Technique In Singapore Provides Improved Outcomes For Blood Cancer Patients
Haplo-2017 is a stem cell transplant technique for that enables the acceptance of stem cells from donors previously deemed unsuitable.
Haplo-2017 is a stem cell transplant technique for that enables the acceptance of stem cells from donors previously deemed unsuitable.
Members of the public interested in learning about breast augmentation surgery in Thailand are invited to a free webinar on 15 December 2022.
The video recap of our webinar on Understanding the Cost of Cancer Treatment in Singapore and How to Manage The Financial Impact Of Cancer is now available on our video resources page.
Ms Pamela Chong (Associate Manager, TN Advisory Group) explains how to financially plan against the cost of cancer treatment in Singapore.
Dr Wong Siew Wei (medical oncologist, Parkway Cancer Centre) and Ms Pamela Chong (Associate Manager with TN Advisory Group) discussed the cost of cancer drug treatment and how to manage the financial impact of cancer at our webinar on 30 Sep 22.
Strategic Partnership with ShareInvestor Through our strategic partnership with ShareInvestor, one of the biggest financial news hub in SG and MY, we share quality healthcare and aesthetic content to their strong subscriber base of investment-savvy, high networth individuals. Who Is ShareInvestor? ShareInvestor is an integrated investor communication company with operations across South East Asia. They […]
Coronary heart disease is a common affliction in Singapore. Learning how to prevent coronary heart disease can help save lives.
Free webinar on understanding the cost of cancer drug treatments in Singapore and how we can be prepared for the potential financial impact.
Researchers lead by A/P from the NUS School of Medicine make discovery that can lead to more successful breast cancer treatments in Singapore.
Immunotherapy is a novel, precision form of cancer treatment that makes use of the body’s immune system to help fight against the cancer.
We noticed you are visiting from .
Please select the language in which you would like to see the content.